Evaluation of B cell maturation antigen as a target for antibody drug conjugate mediated cytotoxicity in multiple myeloma.
about
Emerging antibody-drug conjugates for treating lymphoid malignancies.Immunologic approaches for the treatment of multiple myeloma.Monoclonal antibody therapy in multiple myeloma.CAR T cell therapy for multiple myeloma: where are we now and where are we headed?An APRIL based chimeric antigen receptor for dual targeting of BCMA and TACI in Multiple Myeloma.Effective Targeting of Multiple B-Cell Maturation Antigen-Expressing Hematological Malignances by Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T Cells.
P2860
Evaluation of B cell maturation antigen as a target for antibody drug conjugate mediated cytotoxicity in multiple myeloma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Evaluation of B cell maturatio ...... otoxicity in multiple myeloma.
@en
type
label
Evaluation of B cell maturatio ...... otoxicity in multiple myeloma.
@en
prefLabel
Evaluation of B cell maturatio ...... otoxicity in multiple myeloma.
@en
P2093
P2860
P356
P1476
Evaluation of B cell maturatio ...... otoxicity in multiple myeloma.
@en
P2093
Danton Bounds
Fiona M Germaschewski
Gaelle Herledan
James Tunstead
Jennifer Paterson
Jenny L Craigen
Katherine Sully
Kwee L Yong
Laura M Seestaller-Wehr
Lee McCahon
P2860
P304
P356
10.1111/BJH.14145
P407
P577
2016-06-17T00:00:00Z